Hms Capital Management, LLC Bristol Myers Squibb CO Put Options Transaction History

Hms Capital Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $21,928 - $25,636	400 New	400 $24,000
Q4 2019 Jan 29, 2020	SELL	$49.21 - $64.19 $615,125 - $802,375	-12,500 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $534,625 - $633,875	12,500 New	12,500 $633,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $1.13 Million - $1.35 Million	-25,000 Closed	0 $0
Q4 2018 Jan 14, 2019	BUY	$48.76 - $63.23 $609,500 - $790,375	12,500 Added 100.0%	25,000 $1.3 Million
Q3 2018 Nov 02, 2018	BUY	$55.19 - $62.25 $689,875 - $778,125	12,500 New	12,500 $776,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hms Capital Management, LLC with notifications on news.